GOSSAMER BIO, INC. (GOSS) Shareholders’ equity 2022–2025
GOSSAMER BIO, INC. (GOSS) shareholders’ equity at each fiscal year-end, per SEC filings.
-$122.8MFY2025 · since FY2022: $12.1M → -$122.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$122.8M | -516.2% |
| FY2024 | $29.5M | -53.0% |
| FY2023 | $62.8M | +419.7% |
| FY2022 | $12.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice